| scholarly article | Q13442814 |
| P50 | author | Robert S Daum | Q106083100 |
| P2093 | author name string | Fan Zhao | |
| Maria-Luisa Alegre | |||
| Christopher P Montgomery | |||
| Anita S Chong | |||
| Melvin Daniels | |||
| P2860 | cites work | Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department | Q55897489 |
| Induction of antibodies by Staphylococcus aureus nasal colonization in young children | Q84733144 | ||
| Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic | Q24614464 | ||
| Vaccine protection against Staphylococcus aureus pneumonia | Q24650703 | ||
| Progress toward a Staphylococcus aureus vaccine | Q26829702 | ||
| Two genes on A/J chromosome 18 are associated with susceptibility to Staphylococcus aureus infection by combined microarray and QTL analyses | Q28512431 | ||
| Genomic responses in mouse models poorly mimic human inflammatory diseases | Q29547718 | ||
| Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome | Q29614595 | ||
| Invasive methicillin-resistant Staphylococcus aureus infections in the United States | Q29616087 | ||
| Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice | Q33521257 | ||
| The Zwitterionic Cell Wall Teichoic Acid of Staphylococcus aureus Provokes Skin Abscesses in Mice by a Novel CD4+ T-Cell-Dependent Mechanism | Q33719517 | ||
| Heterogeneity of the humoral immune response following Staphylococcus aureus bacteremia | Q33788390 | ||
| IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice | Q33815790 | ||
| Nontoxigenic protein A vaccine for methicillin-resistant Staphylococcus aureus infections in mice | Q34096536 | ||
| Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model | Q34154110 | ||
| CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections | Q34772232 | ||
| Identifying protective antigens of Staphylococcus aureus, a pathogen that suppresses host immune responses | Q35225082 | ||
| Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care | Q36023547 | ||
| Subcutaneous staphylococcal infection in mice. I. The role of cotton-dust in enhancing infection | Q36167808 | ||
| Immunization with Staphylococcus aureus iron regulated surface determinant B (IsdB) confers protection via Th17/IL17 pathway in a murine sepsis model | Q36184397 | ||
| Vaccination with a UV-irradiated genetically attenuated mutant of Staphylococcus aureus provides protection against subsequent systemic infection. | Q36368669 | ||
| The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus | Q36898452 | ||
| The arginine catabolic mobile element is not associated with enhanced virulence in experimental invasive disease caused by the community-associated methicillin-resistant Staphylococcus aureus USA300 genetic background | Q37256515 | ||
| Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome | Q37273205 | ||
| Immunity against Staphylococcus aureus cutaneous infections | Q37896454 | ||
| Methicillin-resistant Staphylococcus aureus (MRSA) infections among HIV-infected persons in the era of highly active antiretroviral therapy: a review of the literature | Q37978658 | ||
| Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial | Q38453557 | ||
| IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection | Q39964187 | ||
| Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk | Q41714469 | ||
| Staphylococcus aureus induces type I IFN signaling in dendritic cells via TLR9. | Q41761160 | ||
| Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model | Q42046035 | ||
| National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections | Q43516352 | ||
| Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. | Q44894318 | ||
| IFN-gamma plays a detrimental role in murine defense against nasal colonization of Staphylococcus aureus | Q47843383 | ||
| T and B cells are not required for clearing Staphylococcus aureus in systemic infection despite a strong TLR2-MyD88-dependent T cell activation. | Q53285398 | ||
| Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. | Q53979462 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Staphylococcus aureus | Q188121 |
| antibody | Q79460 | ||
| interleukins | Q194908 | ||
| skin infection | Q2458539 | ||
| P304 | page(s) | 2125-2134 | |
| P577 | publication date | 2014-03-10 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A. | |
| P478 | volume | 82 |
| Q48551373 | A D-Alanine Auxotrophic Live Vaccine is Effective against Lethal Infection Caused by Staphylococcus aureus. |
| Q35758457 | A Multiple Antigenic Peptide Mimicking Peptidoglycan Induced T Cell Responses to Protect Mice from Systemic Infection with Staphylococcus aureus |
| Q38415816 | A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults. |
| Q38751767 | Adaptive Immunity Against Staphylococcus aureus. |
| Q26771957 | Advances in T Helper 17 Cell Biology: Pathogenic Role and Potential Therapy in Multiple Sclerosis |
| Q40416064 | Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo |
| Q40177898 | Antibody-mediated protection against Staphylococcus aureus dermonecrosis and sepsis by a whole cell vaccine |
| Q36380959 | Antigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureus |
| Q42583376 | Antimicrobial activity of isothiocyanates from cruciferous plants against methicillin-resistant Staphylococcus aureus (MRSA). |
| Q34250054 | Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus. |
| Q98735574 | Challenges for Clinical Development of Vaccines for Prevention of Hospital-Acquired Bacterial Infections |
| Q92021300 | Clonal Vγ6+Vδ4+ T cells promote IL-17-mediated immunity against Staphylococcus aureus skin infection |
| Q50199724 | Clonally expanded γδ T cells protect against Staphylococcus aureus skin reinfection |
| Q38651177 | Deciphering the significance of the T-cell response to Staphylococcus aureus |
| Q92003682 | Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms |
| Q33854487 | Epic Immune Battles of History: Neutrophils vs. Staphylococcus aureus |
| Q40245675 | Evaluation of serotypes 5 and 8 capsular polysaccharides in protection against Staphylococcus aureus in murine models of infection |
| Q27005777 | Host factors that contribute to recurrent staphylococcal skin infection |
| Q40342616 | IL-10 Plays Opposing Roles during Staphylococcus aureus Systemic and Localized Infections. |
| Q93115631 | Immune and Inflammatory Reponses to Staphylococcus aureus Skin Infections |
| Q36409380 | Immunomodulation and Disease Tolerance to Staphylococcus aureus |
| Q40617495 | Impact of Staphylococcus aureus USA300 Colonization and Skin Infections on Systemic Immune Responses in Humans |
| Q36735408 | Importance of B Lymphocytes and the IgG-Binding Protein Sbi in Staphylococcus aureus Skin Infection |
| Q54246789 | Individual variation is the key to the development of a vaccine against Staphylococcus aureus: a comparative study between mice lineages. |
| Q91745147 | Inhibition of protective immunity against Staphylococcus aureus infection by MHC-restricted immunodominance is overcome by vaccination |
| Q37611964 | Innate Immune Memory Contributes to Host Defense against Recurrent Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus |
| Q53703393 | Isothiocyanates: An Overview of Their Antimicrobial Activity against Human Infections. |
| Q47149275 | Lipid moieties on lipoproteins of commensal and non-commensal staphylococci induce differential immune responses. |
| Q36032570 | MF59- and Al(OH)3-Adjuvanted Staphylococcus aureus (4C-Staph) Vaccines Induce Sustained Protective Humoral and Cellular Immune Responses, with a Critical Role for Effector CD4 T Cells at Low Antibody Titers |
| Q34792962 | Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection. |
| Q35833250 | Memory Th1 Cells Are Protective in Invasive Staphylococcus aureus Infection. |
| Q34059043 | Microbiota-driven immune cellular maturation is essential for antibody-mediated adaptive immunity to Staphylococcus aureus infection in the eye. |
| Q35659395 | Mild Staphylococcus aureus Skin Infection Improves the Course of Subsequent Endogenous S. aureus Bacteremia in Mice |
| Q35880774 | Multiple B-cell epitope vaccine induces a Staphylococcus enterotoxin B-specific IgG1 protective response against MRSA infection |
| Q54267472 | Neutrophils in hot pursuit of MRSA in the lymph nodes. |
| Q36138054 | Nonredundant Roles of Interleukin-17A (IL-17A) and IL-22 in Murine Host Defense against Cutaneous and Hematogenous Infection Due to Methicillin-Resistant Staphylococcus aureus. |
| Q41994684 | O-Acetylation of Peptidoglycan Limits Helper T Cell Priming and Permits Staphylococcus aureus Reinfection. |
| Q57459066 | Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms |
| Q57295966 | Protective immunity in recurrent infection reflects localized immune signatures and macrophage-conferred memory |
| Q35947359 | Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin Infection |
| Q35930390 | Quantifying the natural history of biofilm formation in vivo during the establishment of chronic implant-associated Staphylococcus aureus osteomyelitis in mice to identify critical pathogen and host factors. |
| Q35526164 | RNA-Seq Analysis of the Host Response to Staphylococcus aureus Skin and Soft Tissue Infection in a Mouse Model |
| Q64243557 | Retrospective Identification of a Broad IgG Repertoire Differentiating Patients With Skin and Soft Tissue Infections From Controls |
| Q89821714 | Risk stratification biomarkers for Staphylococcus aureus bacteraemia |
| Q92436768 | Role and plasticity of Th1 and Th17 responses in immunity to Staphylococcus aureus |
| Q30239977 | Staphylococcus aureus in the Intensive Care Unit: Are These Golden Grapes Ripe for a New Approach? |
| Q36735452 | The T Cell Response to Staphylococcus aureus |
| Q36294442 | Vaccination with Klebsiella pneumoniae-derived extracellular vesicles protects against bacteria-induced lethality via both humoral and cellular immunity |
| Q92278070 | Vaccination with a live-attenuated small-colony variant improves the humoral and cell-mediated responses against Staphylococcus aureus |
| Q30397807 | Wall teichoic acids mediate increased virulence in Staphylococcus aureus |
Search more.